Search Results - "Peppard, R F"

Refine Results
  1. 1

    The reach-to-grasp movement in Parkinson’s disease before and after dopaminergic medication by Castiello, U., Bennett, K.M.B., Bonfiglioli, C., Peppard, R.F.

    Published in Neuropsychologia (2000)
    “…The aim of the present study was to assess the effects of dopaminergic medication on the organisation of the reach-to-grasp movement in Parkinson’s disease. A…”
    Get full text
    Journal Article
  2. 2

    The reach-to-grasp movement in Parkinson's disease : response to a simultaneous perturbation of object position and object size by CASTIELLO, U, BENNETT, K, BONFIGLIOLI, C, LIM, S, PEPPARD, R. F

    Published in Experimental brain research (01-04-1999)
    “…This study assessed the adaptive response of the reach-to-grasp movement of 12 Parkinson's disease (PD) and 12 control subjects to a simultaneous perturbation…”
    Get full text
    Journal Article
  3. 3

    Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis by WOLTERS, E. C, HURWITZ, T. A, MAK, E, TEAL, P, PEPPARD, F. R, REMICK, R, CALNE, S, CALNE, D. B

    Published in Neurology (01-05-1990)
    “…In a double-blind placebo-controlled study, we evaluated the effects of clozapine (75 to 250 mg/day, mean 170.8) on dopaminomimetic psychosis and parkinsonian…”
    Get full text
    Journal Article
  4. 4

    Positron emission tomography in manganese intoxication by Wolters, E C, Huang, C C, Clark, C, Peppard, R F, Okada, J, Chu, N S, Adam, M J, Ruth, T J, Li, D, Calne, D B

    Published in Annals of neurology (01-11-1989)
    “…We employed 6-fluorodopa to study the integrity of the nigrostriatal dopaminergic projection by positron emission tomography in 4 subjects with clinical…”
    Get more information
    Journal Article
  5. 5

    Cortical glucose metabolism in Parkinson's and Alzheimer's disease by Peppard, R F, Martin, W R, Clark, C M, Carr, G D, McGeer, P L, Calne, D B

    Published in Journal of neuroscience research (01-12-1990)
    “…Characteristic regional patterns of decreased cerebral glucose metabolism (rCMRG) have been described in a variety of neurodegenerative conditions associated…”
    Get more information
    Journal Article
  6. 6

    The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement by Bennett, Kerry M B, O’Sullivan, John D, Peppard, Richard F, McNeill, Peter M, Castiello, Umberto

    “…OBJECTIVE to assess postoperative effects of unilateral posteroventral pallidotomy on the organisation of upper limb movement. METHODS A three dimensional…”
    Get full text
    Journal Article
  7. 7

    Left posteroventral pallidotomy results in a deficit in verbal memory by Crowe, S.F., O'Sullivan, J.D., Peppard, R.F., McNeill, P.M., Bardenhagen, F., Bowden, S.

    Published in Behavioural neurology (1998)
    “…Whilst pallidotomy is emerging as a popular approach to the treatment to Parkinson's disease, little is yet known about the cognitive effects of this…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Dopaminergic effects on the implicit processing of distractor objects in Parkinson's disease by CASTIELLO, U, BONFIGLIOLI, C, PEPPARD, Richard F

    Published in Experimental brain research (01-11-2000)
    “…The aim of the present study was to assess the effects of dopaminergic medication on the selection-for-action mechanisms in Parkinson's disease (PD). PD…”
    Get full text
    Journal Article
  10. 10

    Parkinsonism with neuroacanthocytosis by Peppard, R F, Lu, C S, Chu, N S, Teal, P, Martin, W R, Calne, D B

    Published in Canadian journal of neurological sciences (01-08-1990)
    “…Two patients with neuroacanthocytosis are described. One presented with parkinsonism and the other resembled diurnal dystonia of the Segawa type. Both patients…”
    Get more information
    Journal Article
  11. 11

    PET studies of parkinsonian patients treated with autologous adrenal implants by Guttman, M, Burns, R S, Martin, W R, Peppard, R F, Adam, M J, Ruth, T J, Allen, G, Parker, R A, Tulipan, N B, Calne, D B

    Published in Canadian journal of neurological sciences (01-08-1989)
    “…Transplantation of autologous adrenal medulla tissue into the striatum has recently been proposed as a treatment for Parkinson's disease. We report the use of…”
    Get more information
    Journal Article
  12. 12

    Aging of the nigrostriatal pathway in humans by Calne, D B, Peppard, R F

    Published in Canadian journal of neurological sciences (01-08-1987)
    “…Progressive degeneration of functionally related groups of neurons occurs in certain infective, toxic, nutritional and genetically determined neurological…”
    Get more information
    Journal Article
  13. 13

    Diffuse Lewy body disease and progressive dementia in a young woman by Crowe, S F, Peppard, R F, Borenstein, R, Lloyd, J H

    “…This report details the emergence of a progressive parkinsonian syndrome, dementia and behavioural disturbance in a 33 year-old woman which can be dated to the…”
    Get more information
    Journal Article
  14. 14

    Decreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants by Tsui, J K, Peppard, R F, Petruk, K C, Allen, G, Burns, R S, Calne, D B

    Published in Neurology (01-05-1990)
    “…We studied 6 parkinsonian patients 6 weeks after unilateral adrenal-to-caudate implants. We withheld medications the night before each of 2 study days and gave…”
    Get full text
    Journal Article
  15. 15

    Cerebral glucose metabolism in Parkinson's disease with and without dementia by Peppard, R F, Martin, W R, Carr, G D, Grochowski, E, Schulzer, M, Guttman, M, McGeer, P L, Phillips, A G, Tsui, J K, Calne, D B

    Published in Archives of neurology (Chicago) (01-12-1992)
    “…Although cognitive impairment is commonly associated with Parkinson's disease, the relative importance of cortical and subcortical pathologic changes to the…”
    Get more information
    Journal Article
  16. 16

    A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease by TSUI, J. K. C, WOLTERS, E. C, PEPPARD, R. F, CALNE, D. B

    Published in Neurology (01-06-1989)
    “…We carried out a double-blind rising dose study of a D-1 dopamine agonist, CY 208-243, in 6 parkinsonian patients. Deficits monitored by Columbia scores were…”
    Get full text
    Journal Article
  17. 17

    Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam by Snow, B J, Peppard, R F, Guttman, M, Okada, J, Martin, W R, Steele, J, Eisen, A, Carr, G, Schoenberg, B, Calne, D

    Published in Archives of neurology (Chicago) (01-08-1990)
    “…We performed positron emission tomography using 18F-6-fluorodopa on four Guamanians with an amyotrophic lateral sclerosis syndrome, eight Guamanians with…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Cryoglobulinaemic neuropathy--a clinical spectrum by Peppard, R F, Byrne, E, Anderson, R M, Clarke, B G

    “…In this report we present two cases who illustrate both ends of the spectrum of neuropathy with cryoglobulinaemia. Both patients responded well to treatment. A…”
    Get more information
    Journal Article
  20. 20

    Unilateral pallidotomy for Parkinson’s disease disrupts ocular fixation by O’Sullivan, John D, Maruff, Paul, Tyler, Peter, Peppard, Richard F, McNeill, Peter, Currie, Jon

    Published in Journal of clinical neuroscience (01-03-2003)
    “…Although some motor functions of the basal ganglia have been well studied, the oculomotor functions are not well established. We studied eye movements in…”
    Get full text
    Journal Article